Global Pharmaceutical Drugs Market Opportunities and Strategies 2018-2021 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Sep 27, 2018--The “Pharmaceutical Drugs Global Market Opportunities And Strategies To 2021” report has been added to ResearchAndMarkets.com’s offering.
The global pharmaceutical drug market was worth $934.8 billion in 2017 and has grown at a CAGR of 5.16% during 2013-2017. The market is expected to grow at a CAGR of 5.78% during 2017-2021 and is forecast to be worth $1,170.4 billion by 2021.
Global GDP is expected to grow significantly to 2021, so the 5.78% annual growth of the global pharma market does not register in the percentage figures. Aging populations, income growth especially in emerging economies and the high prices of new drugs are factors leading to steadily increasing per capita drugs expenditure.
At the global level, pharmaceutical drugs are segmented based on the therapeutic area with drugs for musculoskeletal disorders as the largest segment worth $130.2 billion in 2017. Cardiovascular drugs were the second largest segment followed by oncology drugs with a market worth $129.6 billion and 125.9 billion respectively. Ophthalmology Drugs was the smallest major segment in the pharmaceutical drugs market worth about $27.7 billion.
Key Topics Covered:Executive Summary Pharmaceutical Drugs Market Characteristics Global Pharmaceutical Drugs Market, PESTLE Analysis Pharmaceutical Drugs Market Customer Information Pharmaceutical Drugs Market Regional And Country Analysis Global Pharmaceutical Drugs Market Segmentation Pharmaceutical Drugs Market Segments And Subsegments Pharmaceutical Drugs Market Comparison With Macro Economic Factors Pharmaceutical Drugs Market Comparison With Industry Metrics Global Pharmaceutical Drugs Market Competitive Landscape Key Mergers And Acquisitions In The Pharmaceutical Drugs Market Pharmaceutical Drugs Market Trends And Strategies Market Background: Healthcare Market
North America:3M Pharmaceuticals Abbott Laboratories AbbVie Amgen Astellas Pharma Eli Lilly and Company F. Hoffmann-La Roche Gilead Science Johnson & Johnson Merck & Co. Pfizer Inc. Q Pharm
Asia-Pacific:Cipla Daiichi Sankyo Dr. Reddy’s Laboratories Ltd. Otsuka Pharmaceutical Co. Ltd. Shanghai Fosun Pharmaceutical Shanghai Pharmaceuticals Sun Pharma Takeda Pharmaceutical Company Ltd.
Western Europe:AstraZeneca Bayer Boehringer Ingelheim GlaxoSmithKline Novartis Novo Nordisk Roche Sanofi Teva Pharmaceutical Industries
South America:Ache AstraZeneca Bayer Biolab Farmaceutica Boehringer Ingelheim Cristalia EMS Pharma Eurofarma GlaxoSmithKline Hypermarcas Libbs Medley Merck Novartis Pfizer Roche Sanofi Takeda Teuto Brasileiro Unio Quimica Eatern Europe: AKRIKHIN Aventis Bayer GlaxoSmithKline Microgen Novartis Pfizer Pharmstandard Roche Sanofi Sotex STADA CIS Russian Holding
Middle East:Abbott Laboratories GSK Gulf Pharmaceutical Industries (Julphar) Merck Pfizer Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO)
Africa:Adcock Ingram Aspen Bayer Cipla Johnson & Johnson Novartis Pfizer Roche Sanofi
For more information about this report visit https://www.researchandmarkets.com/research/vhkth9/global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180927005327/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 09/27/2018 05:01 AM/DISC: 09/27/2018 05:00 AM